Abstract |
Excessive enterogastric reflux following partial gastrectomy is believed to be responsible for the cause of inflammation in the gastric remnant. We examined the effect of FUT-187, a synthetic serine protease inhibitor, on symptoms and endoscopic findings in 33 patients who were diagnosed endoscopically as postgastrectomy gastritis. Patients took 50 mg FUT-187 orally after each meal and at bedtime for 8 weeks. Before treatment, 30 patients (91%) suffered from several symptoms including regurgitation and/or bitter taste in the mouth (49%), epigastric pain (42%) and nausea (36%). From endoscopic observation, erythema was detected in 32 patients, edema in 23 patients and erosion and/or ulcer in 9 patients. After treatment the global improvement rating for subjective symptoms was 76.7% (23/30) and the improvement of endoscopic findings was 63.6% (21/33). Diarrhea was observed in one patient but could be easily controlled by discontinuation of the drug. Our results suggest that FUT-187 can be a useful drug for the treatment of postgastrectomy gastritis with its efficacy and safety.
|
Authors | H Shiozaki, M Inoue, S Tamura, T Iwanaga, M Imaoka, H Furukawa, M Hiratsuka, N Kikkawa, K Kobayashi, J Okamura, N Takada, Y Ogawa, T Yamada, M Takami, T Takada, H Okuda, T Yano, T Satomi, T Kawasaki, S Oshima, K Yamasaki, H Imamoto, S Noguchi, N Fujimoto, T Mori |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 23
Issue 14
Pg. 1971-9
(Dec 1996)
ISSN: 0385-0684 [Print] Japan |
PMID | 8978806
(Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study)
|
Chemical References |
- Imidazoles
- Protease Inhibitors
- sepimostate mesilate
|
Topics |
- Administration, Oral
- Adult
- Aged
- Gastrectomy
(adverse effects)
- Gastric Stump
- Gastritis
(drug therapy)
- Humans
- Imidazoles
(therapeutic use)
- Middle Aged
- Postoperative Complications
(drug therapy)
- Protease Inhibitors
(therapeutic use)
|